Long-term safety and tolerability of acoramidis (ag10) in symptomatic transthyretin amyloid cardiomyopathy: updated analysis from an ongoing phase 2 open-label extension study
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要